Executive Order 14401: Accelerating Medical Treatments for Serious Mental Illness

Executive Order 14401 outlines a federal strategy to accelerate the development and approval of innovative treatments for serious mental illness, including the use of psychedelic compounds. It directs the FDA to prioritize review pathways and expand access through programs like Right to Try, while encouraging collaboration across HHS, the VA, and state governments. The order allocates funding to support research, clinical trials, and data sharing to improve treatment outcomes, particularly for veterans and patients who do not respond to traditional therapies. It also calls for streamlined rescheduling processes for approved therapies, aiming to address rising suicide rates and improve long-term mental health care nationwide.